Updates

There has been a delay of the Revised Common Rule.

In response to rising costs associated with growing regulatory demands related to clinical research, fees associated with reviews of industry sponsored clinical trials involving human subjects research will be increasing as of July 1, 2019.

Part 1: Overview

In ongoing efforts to improve efficiency and reduce burden, research submissions in WVU+kc will no longer require sign-off by a unit administrator (UA). Instead, UAs will receive notifications of study submissions via email that require no additional action.